Aether Industries Ltd. · NSE:AETHER
Aether Industries — Investor Presentation (June 2023)
34 slides from Aether Industries's investor presentation, Jun 6, 2023
Slide 1: Stock exchange filing cover letter
June 6, 2023 Ref. No.: AIL/SE/28/2023-24 To, BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Fort, Bandra Kurla Complex, Bandra (E), Mumbai-400001, MH. Mumbai-400051, MH. Scrip Code: 543534 Symbol: AETHER Dear Madam / Sir, Subject: Invest
Slide 2: June 2023
June 2023
Slide 3: Disclaimer
DISCLAIMER This investor presentation has been prepared by Aether Industries Limited and does not constitute a prospectus or placement memorandum or an offer to acquire any securities. This presentation or any other documentation or information (or any part thereof), delivered or supplied, should no
Slide 4: Why Aether?
WHY AETHER? The True Story R&D Driven Approach Growth Engines 1st Time In India [8 x 8] Matrix of chemistry/ Specialised R&D team Successfully launched 3 Most of our advanced technology competencies comprising 233 highly business models in 5 years intermediates and developed in-house, from qualified
Slide 5: Evolution of Aether | 2022 Onwards
EVOLUTION OF AETHER | 2022 ONWARDS 2022 2023 Scaling up Expansion • Plot No. 14 + 15, approx. 125,874.64 sq.m. acquired in Panoli GIDC • Commercial production commenced at Manufacturing Facility 3 • Revenue from operations of ₹ 5,900 MM achieved (8202/1, GIDC, Sachin, Surat) • Successfully launched
Slide 6: IPO
IPO An important milestone in the history of any company is when it is listed on stock exchanges. We, Aether Industries Limited, successfully launched our IPO and got listed on June 3, 2022 on the stock exchanges in India.
Slide 7: R&D Centre Inauguration
R&D Centre Inauguration Company’s newly expanded Research & Development Centre was inaugurated on Tuesday, October 11, 2022. The ribbon-cutting ceremony to inaugurate the Newly Expanded R&D Laboratory was done by Padma Vibhushan Professor Dr. Man Mohan Sharma as the Chief Guest, in the presence of o
Slide 8: Aether Sites (Chemical Zones, Gujarat, India)
AETHER SITES (Chemical Zones, Gujarat, India) S1 - Hojiwala S2 - 8203 S3 - 8202 S4 - 362, 363 21.140686° N, 72.8160973° E 21.1406860° N, 72.8160973° E 21.0895827° N, 72.8481159° E 21.0933241° N, 72.8137618° E Presently operational in S-1 Presently operational in S-2 Presently operational in S-3 New
Slide 9: Aether Sites (Chemical Zones, Gujarat, India)
AETHER SITES (Chemical Zones, Gujarat, India) Site - 3 = 10,500 sq. m. Site - 3++ // 8202/2/B Site - 3+ // 8202/2/A Site - 3 // 8202/1 5,250 sq. m. 2,623 sq. m. 2,627 sq. m. l ly Site -2 // 8203 na 10,500 sq. m. g o ite i a os D pp o 200 mtrs. Site - 4 = 18,290 sq. m. Site - 4 // 363 Site - 4 // 362
Slide 10: Production of 3 Products Commenced
SITE 3 Production of 3 Products Commenced Located diagonally opposite to the current Manufacturing Facility 2 in Sachin GIDC, Surat Additional 3500 MT capacities approximately per annum added January 2023 facility operational
Slide 11: Site 5 - Panoli land acquisition
AETHER SITES (Chemical Zones, Gujarat, India) S5 - Panoli 21° 32' 19.302" N, 73° 0' 11.34" E 125,874.64 sq. mtrs. / 31 acres (approximate) Acquired land in GIDC auction for future expansions 12 times the land bank of the current land at Site-2 Easy proximity to NH8 54 Kms drive from current location
Slide 12: Site 5 Inauguration | Blood Donation Camp
SITE 5 INAUGURATION | BLOOD DONATION CAMP 706 Inauguration of Manufacturing Site 5 (Panoli GIDC, Bharuch, Gujarat) was done by brick laying rituals and conducting a blood donation camp. Units Blood Collected
Slide 13: Snapshot
SNAPSHOT (INR MM) Revenue* EBITDA PAT 6,511 1,863 1,304 FY23 10% 11% 20% 5,900 1,681 1,089 FY22 * Revenue from operations EBITDA is calculated as profit before tax + depreciation and amortisation expense + finance costs - other income
Slide 14: Aether Today
AETHER TODAY REVENUE FROM OPERATIONS (INR MM) 34.74%Agro 6,511 5,900 4,498 By Application 8.74% Multiple Pharma 5.71% Photography 42.15% 4.90% Material Science FY21 FY22 FY23 3.35% Coatings 0.41% Others EBITDA% 28.49% 28.61% FY23 24.93% FY21 FY22 FY23 34.31% Domestic 51.56% Contract 31.0% Export# PA
Slide 15: Business Segments
BUSINESS SEGMENTS (INR MM) Large Scale 52% Manufacturing FY21 3,249 FY22 3,955 FY23 3,357 Advanced intermediates and speciality chemicals with application across the industry spectrum Contract Research and Manufacturing 13% Services - CRAMS FY21 359 FY22 479 FY23 817 Contract research, scale-up serv
Slide 16: Global Presence
GLOBAL PRESENCE FY23 6,511 (INR MM) Sales Revenue 1.84% SPAIN 7.98% USA 4.09% GERMANY 15.00% ITALY 59.46% INDIA* 11.63% OTHERS** *includes local sales + deemed exports + SEZ sales ** includes exports to Germany, Taiwan, Mexico, China, Japan, Rest of Europe and Rest of World
Slide 17: Select Marquee Customer Base | Domestic and Global
SELECT MARQUEE CUSTOMER BASE | DOMESTIC AND GLOBAL Pharmaceutical Agrochemical 227 19 Oil and Gas Coatings 4 2 Other Sectors Textiles 56 1 High performance Material photography Science 4 21 As on March 31, 2023
Slide 18: Research and Development
RESEARCH AND DEVELOPMENT R&D has been critical to success and a differentiating factor vis-à-vis competitors Experts at helm of R&D / CRAMS Consistently rising R&D expenditure MARCH-22 MARCH-23 164 233 6.65% 7.70% Highly qualified employees, Highly qualified employees, including including 4.29% (INR
Slide 19: QEHS - Health and Safety
QEHS Health and Safety ISO 9001 INDIAN GMP • Undertaking hazard and operability studies before for Quality for Manufacturing commencing commercial production of new products • Dedicated team of safety personnel • Mobile application for safety and emergencies ISO 45001 UN GLOBAL COMPACT • Modern fire
Slide 20: QEHS
QEHS Quality Environment High standards of quality for products Vibrant infrastructure installed for environment and sustainability efforts To cover To ensure • 100 KLPD in-house zero liquid discharge (ZLD) plant • Triple stage multiple effect evaporator (MEE) • Mechanical vapour recompression (MVR)
Slide 21: Environmental Social Governance
ENVIRONMENTAL SOCIAL GOVERNANCE Environmental Social Governance • Adoption of the green chemistries or • Focused on: • Technically sound and extensively more accurately sustainable chemistry - Education ( especially for girls ) experienced Board members since inception. - Skill development • Transpa
Slide 22: Core Competencies
CORE COMPETENCIES Chemistry Technology Grignards and Continuous Reaction Organolithiations Batch Reaction Ethylene Oxide Chemistry High Pressure Reaction - Tandem Grignard / Fixed Bed Reaction Ethylene Oxide Chemistry Technology Cryogenic Reaction Isobutylene Chemistry High Vacuum Distillation Hydro
Slide 23: Product Selection
Sweet Spot PRODUCT SELECTION Core competencies of chemistry, technology and systems No active manufacturer in India, made for 1st time in India Minimum 4 step sequences of manufacturing and infrastructure oriented Generate adequate revenue at maturity Market leading position at product maturity Prod
Slide 24: Key Pillars
KEY PILLARS • Bachelor of Chemical Engineering from • Bachelor of Chemical Technology - ICT Institute of Chemical Technology (ICT, (UDCT, 2005), PhD in Organic Chemistry from formerly University Department of Michigan State University (USA, 2010) Chemical Technology, UDCT, Mumbai, • Prior to Aether,
Slide 25: Experienced Board
EXPERIENCED BOARD Kamalvijay Tulsian Jeevan Lal Nagori Leja Hattiangadi Dr. Amol Kulkarni Chairman, Non-Executive Non-Executive Independent Non-Executive Independent Non-Executive Independent Director Director Director Director Decades of experience in Experience 34 years in Decades of experience in
Slide 26: Business Development Leaders | SMP and KMP
BUSINESS DEVELOPMENT LEADERS | SMP AND KMP • Bachelor’s Science (Purdue Univ. • Diploma Physics and Doctorate of USA) and PhD Organic Chemistry Natural Sciences (PhD), Univ. (Univ. Wisconsin, USA) Hannover (Germany) • > 30 years at The Dow Chemical • Decades of experience in Company (and subsidiarie
Slide 27: Forward-looking statements disclaimer
Certain statements and opinions with respect to the anticipated future performance of the company in the presentation (“forward - looking statements”), which reflect various assumptions concerning the strategies, objectives and anticipated results may or may not prove to be correct. Such forward -lo
Slide 28: Business Segments
BUSINESS SEGMENTS Particulars (INR MM) FY 2023 FY 2022 FY 2021 Pharmaceuticals ₹ 2,744.05 ₹ 3,513.26 ₹ 3,041.90 Agrochemicals ₹ 2,261.72 ₹ 1,456.19 ₹ 926.50 Miscellaneous / Multiple ₹ 567.63 ₹ 126.66 ₹ 82.66 High Perf. Photo ₹ 371.85 ₹ 283.77 ₹ 125.80 Material Science ₹ 319.33 ₹ 248.20 ₹ 195.90 Coat
Slide 29: Financial Growth
FINANCIAL GROWTH Particulars For the year ended For the year ended For the year ended March 31, 2023 March 31, 2022 March 31, 2021 INR MM (Standalone Financials) Income Revenue from operations ₹ 6,510.74 ₹ 5,900.47 ₹ 4,498.16 Other Income ₹ 165.65 ₹ 69.74 ₹ 39.73 Total income ₹ 6,676.39 ₹ 5,970.21 ₹
Slide 30: Financial Growth
FINANCIAL GROWTH Particulars For the year ended For the year ended For the year ended March 31, 2023 March 31, 2022 March 31, 2021 INR MM (Standalone Financials) Tax expense: Current tax ₹ 311.22 ₹ 338.73 ₹ 201.00 Deferred tax ₹ 129.39 ₹ 36.72 ₹ 25.87 Total Tax Expenses ₹ 440.61 ₹ 375.45 ₹ 226.87 Pr
Slide 31: Key financial ratios and EBITDA
Particulars For the year ended For the year ended For the year ended (Standalone Financials) March 31, 2023 March 31, 2022 March 31, 2021 EBITDA (₹ In MM) ₹ 1862.51 ₹1,681.07 ₹1,121.59 EBITDA Margin (%) 28.61% 28.49% 24.93% PAT (₹ In MM) ₹1,304.17 ₹1,089.29 ₹711.19 PAT Margin (%) 19.53% 18.25% 15.67
Slide 32: Statement of Profit and Loss
STATEMENT OF PROFIT AND LOSS (INR MM) Particulars FY23 FY22 Standalone Financials Audited Audited Revenue from operations 6,511 5,900 Other income 165 70 Total income 6,676 5,970 Cost of goods sold # 3,173 2,880 Employee benefits expense 345 270 Finance cost 51 131 Depreciation & amortization expens
Slide 33: Statement of Assets and Liabilities
STATEMENT OF ASSETS AND LIABILITIES INR MM (Standalone) FY23 FY22 INR MM (Standalone) FY23 FY22 ASSETS EQUITY AND LIABILITIES Non-Current Assets Equity Property, plant and equipment 5,333 2,355 Equity share capital 1,245 1,127 Capital work-in-progress 372 577 Other equity 11,201 2,742 Investments +
Slide 34: Statement of Cash Flows
STATEMENT OF CASH FLOWS INR MM (Standalone) FY23 FY22 Cash generated from operations 253 284 Net cash from operating activities (66) (54) Net cash (used in) investing activities (3,484) (1,509) Cash flow from financing activities Net cash used in financing activities 4,392 1,688 Net increase / (decr
Aether Industries — Investor Presentation (June 2023) on 6ix